IP Library Granted Patent US 7,309,490
Granted Patent B2
US 7,309,490 · App. 11/198,323 · Granted Dec 18, 2007

Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response

Assignee: MedImmune, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,309,490
App. No.
11/198,323
Granted
Dec 18, 2007
Kind
B2
Abstract

Disclosed are methods for vaccine priming, using co-treatment, at a temporally similar or at a previous time, with a priming antibody capable of priming, or enhancing, or potentiating the effects of a vaccine, or vaccine composition. Also disclosed are methods of using this process to prevent or treat disease.

Claims (14)

1. A process for priming the immunogenic activity of a vaccine, comprising:

(a) administering to an animal in need thereof an effective amount of an antibody specific for one or more of the antigenic determinants characteristic of said vaccine useful against a virus and whose immunogenic activity is to be primed; and

(b) administering to said animal an effective amount of the vaccine, of step (a);

wherein said vaccine comprises at least one antigenic determinant for which the antibody of step (a) is not specific, and wherein said virus is selected from the group consisting of: rubella virus, measles virus, pox virus, poliovirus, rabies virus and varicella zoster virus.

2. The process of claim 1 wherein step (a) is carried out at least 24 hours before step (b).

3. The process of claim 1 wherein step (a) is carried out at least 48 hours before step (b).

4. The process of claim 1 wherein step (a) is carried out at least 72 hours before step (b).

5. The process of claim 1 wherein step (a) is carried out at least 1 week before step (b).

6. The process of claim 1 wherein the effective amount of vaccine, is between about 1 mg per kg of body weight to about 1 gram per kg body weight.

7. The process of claim 1 wherein the effective amount of vaccine, is between about 10 mg per kg of body weight to about 1 gram per kg body weight.

8. The process of claim 1 wherein the effective amount of antibody is between 5 to 20 mg/kg of body weight.

9. The process of claim 1 wherein the effective amount of antibody is between 10 to 20 mg/kg body weight.

10. The process of claim 1 wherein the effective amount of vaccine, is between about 5 μper kg of body weight to about 1 gram per kg body weight.

11. The process of claim 1 wherein the effective amount of vaccine, is between about 100 μg per kg of body weight to about 1 gram per kg body weight.

Assignments (1)
CHANGE OF NAME Recorded Sep 9, 2008
From: MEDIMMUNE, INC.
To: MEDIMMUNE, LLC
Reel/Frame 021502/0133 →
Continuity (4)
Continuation 1040982200 · Apr 9, 2003
Continuation 0979776000 · Mar 2, 2001
Provisional Application 6018656600 · Mar 2, 2000
Related Publication 20050276797A1 · Dec 15, 2005